Deck Bio, a biotechnology company advancing multi-pMHC targeted T cell engagers for solid tumors, today presented new preclinical data for its lead program, DBXO-1, at the American Association for ...

Los Angeles, CA – September 8, 2025 - Researchers have harnessed the power of artificial intelligence to tackle one of the most complex challenges in immunology: predicting how T cells recognize and ...

Researchers at Dana-Farber Cancer Institute investigate new features of T cell performance, delineating a class of digital cytotoxic T lymphocytes (CTL) that are optimal in providing protection ...

Peptide-MHC complexes (pMHCs) are central to essential immune decisions, including recognition of infection, autoimmune and tumor eradication. After thymic selection, T cell receptors (TCRs) are the ...

The primary task of T lymphocytes during an immune reaction is to inspect the surface of neighboring cells and identify the presence of external peptide pathogens on antigen-presenting cells (APC) ...

Imagine your immune cells could be modified to attack any kind of cancer. T cell receptor (TCR) therapy has the potential to one day become a universal cancer treatment. But there are risks. Cells ...

Immunotherapy has revolutionized cancer treatment by harnessing the power of T cells to attack tumors. But, even when these treatments are successful, scientists often struggle to understand exactly ...

Until now, the ability of T lymphocytes to distinguish between healthy and infected cells was deemed to be near perfect. New research findings published in eLife show this is not the case. T ...

In a recent study published in Science Advances, researchers presented a deep learning framework, termed DeepAIR, to accurately predict adaptive immune receptor (AIR)-antigen binding by integrating ...